NAFLD
Clinical trials for NAFLD explained in plain language.
Never miss a new study
Get alerted when new NAFLD trials appear
Sign up with your email to follow new studies for NAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug tested to fight fatty liver disease
Disease control Not yet recruitingThis study aims to see if a common type of diabetes drug (GLP-1 RA) can improve the buildup of harmful fats in the liver of people who have fatty liver disease, diabetes, and obesity. Researchers will compare liver and blood samples from 30 people who have been on the drug for a …
Matched conditions: NAFLD
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Apr 01, 2026 22:41 UTC
-
Diabetes pill trial aims to shrink Kids' fatty livers
Disease control Not yet recruitingThis study is testing if a diabetes medication called empagliflozin can safely reduce fat in the liver of teenagers with obesity-related fatty liver disease (NAFLD). Forty adolescents will take the pill or a placebo daily for six months while also receiving lifestyle counseling. …
Matched conditions: NAFLD
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can an 8-Hour eating window reverse fatty liver?
Disease control Not yet recruitingThis study will test if a time-restricted eating pattern helps people with fatty liver disease. 150 participants will either follow an 8-hour daily eating window with fruits and vegetables eaten only during daylight hours, or receive standard dietary advice. Researchers will comp…
Matched conditions: NAFLD
Phase: NA • Sponsor: Cyprus University of Technology • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Natural combo targets silent liver epidemic
Disease control Not yet recruitingThis study is testing whether taking the natural compounds rutin and vitamin C together can help people with fatty liver disease (MASLD). Researchers want to see if this combination reduces liver inflammation and cell damage better than vitamin C alone. The trial will involve 120…
Matched conditions: NAFLD
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New treatment tested for common diabetes complication
Disease control Not yet recruitingThis study aims to see if a treatment called Henggliejin can improve fatty liver disease in people who also have type 2 diabetes. It will involve 149 adults who have both conditions and whose blood sugar is not well controlled. Researchers will measure changes in liver health, bo…
Matched conditions: NAFLD
Phase: EARLY_PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC